Observational study / 2012
Use of glucosamine and chondroitin was associated with a decreased risk of total mortality among older adults.
Researchers evaluated 77,510 participants aged 50-76 years from a Washington State cohort followed from 2000-2002 through 2008, during which 5,362 deaths occurred. Current use of glucosamine (with or without chondroitin) was associated with an adjusted HR for total mortality of 0.82 (95% CI 0.75-0.90), and current chondroitin use had an adjusted HR of 0.86 (95% CI 0.78-0.96) compared to never use. Current glucosamine use was also associated with a decreased risk of death from cancer (HR 0.87, 95% CI 0.76-0.98) and respiratory diseases (HR 0.59, 95% CI 0.41-0.83). The authors note that bias cannot be ruled out.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 77,510 Washington State residents aged 50-76 years
- What was measured
- Cause-specific and total mortality
THE PAPER
Use of glucosamine and chondroitin in relation to mortality.
Bell GA, Kantor ED, Lampe JW, Shen DD, White E. Eur J Epidemiol, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.